when to increase dose of tirzepatide Mounjaro (tirzepatide) - Diabetes & Wieght Loss why do you have to

Understanding the difference is crucial if you want to make an informed choice about what to buy and how much to use

C.SandersR

Both drugs share similar gastrointestinal side effects, and both carry boxed warnings related to thyroid cancer risk and MEN2

The harder question is determining whether fat loss is still happening or whether something needs to change

While certain GLP-1 medications are approved for diabetes and weight loss by the US Food and Drug Administration (FDA), most off-label semaglutide medications are compounded GLP-1s, which are not FDA-approved

GLP-1 can cause nausea, which may lead to reduced fluid intake